Open Access

Yes, MAM: how the cancer-related EMP3 protein became a regulator of erythropoiesis and the key protein underlying a new blood group system

M.D. Ilsley

M.D. Ilsley

Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund UniversityLund, Sweden
Search for this author on
Sciendo|Google Scholar
Ilsley, M.D.
, 
J.R. Storry

J.R. Storry

Experimental Transfusion Medicine, Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Technical Director, Immunohematology, Department of Clinical Immunology and Transfusion Medicine, Office of Medical ServicesLund,
Search for this author on
Sciendo|Google Scholar
Storry, J.R.
 and 
M.L. Olsson

M.L. Olsson

Transfusion Medicine, Deputy Dean, Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Medical Director of the Nordic Reference Laboratory for Genomic Blood Group Typing, Department of Clinical Immunology and Transfusion Medicine, Office of Medical ServicesLund,
Search for this author on
Sciendo|Google Scholar
Olsson, M.L.
  
Dec 28, 2022
Yes, MAM: how the cancer-related EMP3 protein became a regulator of erythropoiesis and the key protein underlying a new blood group system's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Published Online: Dec 28, 2022
Page range: 130 - 136
DOI: https://doi.org/10.21307/immunohematology-2022-055
Keywords
© 2022 M.D. Ilsley et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Laboratory Medicine
Journal RSS Feed